BioCryst Pharmaceuticals Inc (Nasdaq: BCRX) reached $8.18 in late afternoon trading while Cephalon Inc. completes its $615.4 million purchase of Mepha. BioCryst and Cephalon both trade on the “NASDAQ” under the Stock Symbols “BCRX” and “CEPH” For More information regarding “BCRX” and “CEPH”, make sure to visit the Most Exclusive and In Depth newsletter website at: http://www.wallstreetgrand.com/.
Join today and be part of the best free investment newsletter on the web where we focus on market moving news.
BioCryst Pharmaceuticals Inc (Nasdaq: BCRX) reached $8.18 in late afternoon trading on Friday. BioCryst’s stock was up practically 20 percent after elevating 18 cents on Friday.
Cephalon Inc. (NASDAQ:CEPH) completes its $615.4 million purchase of Mepha, which is a Swiss Generic Pharmaceutical Company, which manufactures and markets more than 120 branded and non-branded generic products in more than 50 countries.
You can contact us during market hours at 1-888-9-ClubGrand (1888-925-8247) or via email at staff@wallstreetgrand.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") including 2009 growth, revenue for the second quarter and year of 2009 and gross margin for the second quarter and year of 2009. Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the impact of intense competition, the continuation or worsening of current economic conditions and the condition of the domestic and global credit and capital markets.
Disclaimer:
Wall Street Grand LLC has not been compensated by the company for this press release and does not expect to be compensated in the future for any type of awareness. To read our full disclaimer clicks the link http://www.wallstreetgrand.com/disclosure.html.
